Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-15-002020
Filing Date
2015-08-18
Accepted
2015-08-18 17:19:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO THE SCHEDULE13G sc13ga607422021_08142015.htm SC 13G/A 212937
  Complete submission text file 0000921895-15-002020.txt   214617
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Subject) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-84961 | Film No.: 151062202
SIC: 8731 Services-Commercial Physical & Biological Research